News
31m
Stockhead on MSNHealth Check: Bug buster Genetic Signatures’ US expansion is a jumbo-sized task
Tummy bug testing outfit Genetic Signatures is honing its operations after finding its company-making US expansion was harder ...
4h
Discover Magazine on MSNTwo Cancer Drugs Show Surprising Promise in Treating Alzheimer's
With so few Alzheimer's drugs available, repurposing medications approved for other conditions could be the key to tackling ...
With few treatments available to treat Alzheimer’s disease, scientists have turned to cancer drugs as a potential means of ...
UCSF researchers find that two FDA-approved cancer drugs significantly improve memory in Alzheimer’s mouse models and reduce ...
A standoff over Elevidys could have major consequences for Duchenne patients, gene therapy companies and the perception of ...
Scientists at UCSF and Gladstone Institutes have identified cancer drugs that promise to reverse the changes that occur in ...
A study comparing the gene expression signature of Alzheimer's disease with those elicited by 1,300 approved drugs found a combination of two cancer medications that could treat the most common form ...
An analysis from the Congressional Budget Office warns that cuts to the National Institutes of Health and FDA drug reviews could significantly reduce the number of new medications reaching the U.S.
Drugmaker Sarepta Therapeutics says it won’t comply with a request from U.S. regulators to halt all shipments of its gene ...
Participants in trials of BrainStorm Cell Therapeutics' NurOwn filed a Citizens’ Petition with the FDA earlier this month ...
The U.S. government is nixing a whole slew of "obsolete" U.S. food standards that Trump administration officials say also ...
Vinay Prasad overruled other reviewers for a third time in recent months in clearing only narrow use of Moderna's vaccine in young children.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results